11 Nov 2025

Inmunoterapia y Hemopatías 2025

Hemopathies
On-site
Spanish
HUB Social - Fundació Bofill

Status

Available

Price

Fre

Enter and register!

This workshop is primarily aimed at healthcare professionals working in hematology, oncology, and immunology, as well as specialists involved in the management of hematologic malignancies. It may also be of interest to researchers and medical students who wish to stay informed about the latest advances in the field.

Information

This workshop brings together leading experts in the field of hemato-oncology to explore the latest therapeutic innovations in the treatment of multiple myeloma, with a special focus on immunotherapy and advanced therapies.

Throughout the day, the most recent clinical advances in the use of bispecific antibodies, CAR-T cells, and new immunotherapeutic combinations will be examined, with a practical approach grounded in real-world patient experience. Through presentations and joint discussions, specialists will share outcomes, challenges, and future perspectives in managing this disease.

Program:

Download the program

Coordinators

Eugenia Abella

Specialist physician

Parc de Salut Mar - Hospital del Mar, Barcelona

Eugenia Abella

Specialist physician

Graduate and Doctorate in Medicine and Surgery from the UAB Consultant Assistant Doctor. Hospital del Mar. IMIM Associate Professor of the Faculty of Medicine UAB/UPF
Juan Manuel Sancho

Clinical Hematology Service Chief

ICO Badalona Hospital Universitari Germans Trias i Pujol, Badalona

Juan Manuel Sancho

Clinical Hematology Service Chief

JM Sancho completed his MD at the University of Navarra in 1992, and a residency in Haematology at the Germans Trias i Pujol Hospital in Barcelona. Dr Sancho focused his research in lymphoproliferative disorders, achieving a PhD from the Universitat Autonoma of Barcelona. He is specialist in Hematology-Hemotherapy, Germans Trias i Pujol University Hospital, Badalona. Dr.Sancho is coordinator of the Clinical Hematology Department of the Catalan Institute of Oncology (ICO) and works in the Deparment of Haematology at the Germans Trias I Pujol University Hospital in Badalona, Spain. Also, he is Principal Investigator at the Josep Carreras Leukaemia Research Institute in the grup of Lymphoid Neoplasms. He will contribute to the data base elaboration and will supervise clinical aspects of the project. He is author or co-author of articles and books’ chapters about lymphomas, ALL and stem cell transplantation. Dr. Sancho is the principal investigator in many phases I to IV clinical trials on lymphoproliferative disorders. He is member of the Spanish Society of Haematology (SEHH) and Spanish Lymphoma Group (GELTAMO).

Accreditation

Accreditation submitted to the Consell CFCPS.

Featured Activities